title: TGF-beta 1 inhibition of c-myc transcription and growth in keratinocytes is abrogated by viral transforming proteins with pRB binding domains.
abstract: TGF-beta 1 is demonstrated to inhibit skin keratinocyte proliferation when added during the G1 phase of the cell cycle. Human foreskin keratinocytes transformed with either HPV-16 or -18 or SV40, however, were resistant to the growth inhibitory effects of TGF-beta 1. Since TGF-beta 1 appears to inhibit keratinocyte growth through down-regulation of c-myc, it was hypothesized that these DNA tumor viruses might be modulating the response to TGF-beta 1 via this pathway. Transient expression of proteins HPV-16 E7, adenovirus type 5 E1A, and SV40 large T antigen is demonstrated to block TGF-beta 1 suppression of c-myc transcription. This effect was not observed with DNA tumor virus transforming proteins mutated in their pRB binding domain. These observations indicate that pRB or another protein that interacts with this binding domain mediates TGF-beta 1 regulation of c-myc gene expression and growth inhibition.
authors: Department of Cell Biology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232.
authors: J A
authors: JA
authors: Pietenpol
authors: R W
authors: RW
authors: Stein
authors: E
authors: E
authors: Moran
authors: P
authors: P
authors: Yaciuk
authors: R
authors: R
authors: Schlegel
authors: R M
authors: RM
authors: Lyons
authors: M R
authors: MR
authors: Pittelkow
authors: K
authors: K
authors: Münger
authors: P M
authors: PM
authors: Howley
authors: H L
authors: HL
authors: Moses
mesh_terms: D017456:Adenovirus Early Proteins; D000595:Amino Acid Sequence; D000818:Animals; D000952:Antigens, Polyomavirus Transforming / Q000502:physiology; D002472:Cell Transformation, Viral / Q000502:physiology*; D002478:Cells, Cultured; D004268:DNA-Binding Proteins; D005786:Gene Expression Regulation / Q000502:physiology; D015603:Keratinocytes / Q000502:physiology*; D008969:Molecular Sequence Data; D009856:Oncogene Proteins, Viral / Q000502:physiology*; D010750:Phosphoproteins / Q000378:metabolism / Q000502:physiology; D011518:Proto-Oncogene Proteins / Q000235:genetics*; D016271:Proto-Oncogene Proteins c-myc; D011994:Recombinant Proteins / Q000494:pharmacology; D016160:Retinoblastoma Protein; D014158:Transcription, Genetic; D014162:Transfection; D015291:Transforming Growth Factors / Q000378:metabolism / Q000502:physiology*
chemical_list: D017456:Adenovirus Early Proteins; D000952:Antigens, Polyomavirus Transforming; D004268:DNA-Binding Proteins; C054855:E2 protein, Human papillomavirus type 16; D009856:Oncogene Proteins, Viral; D010750:Phosphoproteins; D011518:Proto-Oncogene Proteins; D016271:Proto-Oncogene Proteins c-myc; D011994:Recombinant Proteins; D016160:Retinoblastoma Protein; D015291:Transforming Growth Factors